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1. Introduction 
The somatomedins (SM) are a group of hepatic 
polypeptide hormones of -7500 mol. wt that are 
growth hormone (GH)-dependent, have insulin-like 
activity and stimulate the growth of a variety of cells 
in culture [l-6]. Their primary function appears to 
be the mediation of the growth-promoting effect of 
GH [l-3], a function strongly supported by the 
recent demonstration that a partially purified prepara- 
tion stimulated the growth of GHdeficient Snell dwarf 
mice [7]. Serum SM levels are primarily increased in 
patients with GH-producing pituitary tumors and 
decreased in GHdeficient dwarfs [ l-3,8-1 11. The 
serum activity may glso be regulated in part by insulin, 
thyroxine, cortisol, estrogen, prolactin and placental 
lactogen [12-201. A unique feature of the SM is that 
they circulate in plasma bound to a large carrier pro- 
tein [21] which influences their biologic activity and 
significantly prolongs their half-life [22]. In addition, 
the kidney plays a role in the catabolism of SM and 
circulating inhibitors affect SM activity [23-271. 
Because of this complex pattern of regulation, pre- 
vious methods for investigating hepatic SM synthesis, 
including liver perfusion [4,13,17] and the ability of 
hormones to reverse somatostatin-induced suppression 
of serum SM levels have given only limited informa- 
tion about hepatic synthesis and are unsuitable for 
investigating intracellular events [181. While hepatoma 
cells and hepatocytes have been observed to produce 
SM [28,29], this is the first report of GH-sensitive, 
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cultured normal rat liver cells that synthesize SM and 
the first demonstration that the liver synthesizes SM 
binding protein. Since these cells retain enzymatic 
activity and synthetic apacity for several days [30], 
they are potentially a good model to study the hor- 
mones that regulate the synthesis of SM and its bind- 
ing protein. 
2. Materials and methods 
2.1. Materials 
Rat GH (NIH Bs, 0.9 U/mg) was provided by the 
Endocrine Study Section, NIH, Bethesda, MD. 
2.2. Cell culture 
Hepatocytes were obtained from male Sprague 
Dawley rats (250 g) 4 days after a 70% hepatectomy. 
Under ether anesthesia the liver was perfused with 
500 ml Ca*- and Mg2+-free Eagle’s medium 199 con- 
taining 200 mg collagenase (Gibco), 100 U penicillin 
G and 1.8 mg NaHCOa. The first 20 ml perfusate was 
discarded and the remaining recirculated for 20 min. 
The liver was removed, placed in 75 ml perfusion 
medium and shaken for 15 min at 37°C. After the 
Ca* concentration was adjusted to 0.35 mM, the 
mixture was filtered through nylon mesh. The hepa- 
tocytes were spun at 50 X g for 3 mm at 25”C, washed 
with complete Eagle’s medium, and suspended in the 
same medium at 1.5 X lo6 cells/ml. Cell viability was 
determined by trypan blue exclusion and averaged 
80%. The yield was 100-200 X IO6 cells/liver. 
Cultures were initiated by adding 3 ml cell suspension 
to 5 cm Falcon petri dishes precoated with rat tail 
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collagen. After 4 h the cells were adherent and the 
“‘I-SWA WUND I! 
medium was changed. fcpmxlo*) 
2.3. Radioreceptor assay and bioassay 
The human placental membrane competitive bind- 
ing assay used was a modification of the method in 
[IO]. Details of this method are in [24,31]. SM-A 
(neutral somatomed~) was prepared by Dr K. Uthne 
from human Cohn fraction IV by acid-ethanol extrac- 
tion, gel chromatography and zone electrophoresis 
[32-341. The SM-A preparation used for labeling was 
homogeneous by electrophoresis and CM-52 cellulose 
chromatography and had an activity of 1250 Ufmg in 
the radioreceptor assay. SM-A was iodinated to 
80-l 20 @i/pg spec. act. [35]. Radioligand and non- 
specific bindings averaged 23% and < 2%. Normal 
human serum, SM-A, SM-C (basic SM) and insulin-like 
growth factor-I gave parallel displacement curves. 
Serum activity was expressed relative to a pool of 
normal sera for 10 healthy adults arbitra~Iy assigned 
a value of 1 .O U/ml. The mean levels + SE were 
1.06 f 0.06 for 39 normal adults, 0.35 + 0.03 for 
9 GHdeficient subjects and 3.2 1 + 0.4 U/ml for 
12 acromegalic patients. The interassay coefficient of 
variation was 6%. 
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Fig.1. Somatomedin synthesis by rat hepatocytes in mono- 
layer culture measured by radioreceptor assay. (a) The dose 
response curves of hepatocyte culture medium and standard 
normal human serum. (b) The effect of growth hormone on 
somatomedin synthesis. Rat growth hormone was added at 
4 h and somatomedin production was measured at 24 h. The 
results are means (* SE) per 24 h, n = 4. 
Bioactivity was measured by 35S04 incorporation 
into embryonic hicken pelvic leaflets [36]. The index 
of precision (X) averaged 0.23. 
2.4. Chromatography 
Columns of Sephadex G-75 fO.9 X 70 cm) were 
equilibrated with either 0.1 M ammonium formate or 
1 M acetic acid at 25OC. A 6 X concentrate of hepatic 
media (1 .S ml) was applied to each and eluted frac- 
tions tested by radioreceptor assay. 
shown). Since all SM crossreact in this receptor assay 
[37], the measured value reflects total SM produc- 
tion. Released SM represents de novo synthesis ince 
there is no appreciable hepatic storage of SM [2]. 
Cell cultures from regenerating rat livers were used 
because they synthesized almost wice as much SM 
as normal cells (data not shown) and could be cultured 
from inception in entirely serum-free media thereby 
avoiding addition of exogenous serum factors. 
3. Results 
Primary monolayer cultures of rat parenchymal 
liver cells were found to release -48 U SM .24 h-l . 
liver-‘. Figure la shows the parallel dose-response 
curves for the standard SM serum and hepatocyte 
culture medium using ‘“51-labeled SM-A as the radio- 
ligand in the radioreceptor assay. Although parallel 
dose-response curves were also obtained with 
1251-labeled SM-C (basic SM) as the radioligand, 
1251-labeled SM-A gave improved sensitivity (data not 
Hepatocytes retained their functional capacity to 
respond to GH stimulation with significant increases 
in SM production of 28% and 36% at SO nglml and 
150 npJm1, respectively (fig.lb). The SM measured by 
radioreceptor assay was determined to be biolog- 
ically active SM for the hepatocyte culture media 
was able to stimulate the incorporation of 35S04 into 
embryonic hick pelvic cartilage. Figure 2a shows 
that the log dose-response curve for hepatocyte 
culture medium from 5-60% was parallel to that for 
the standard serum. The yield calculated for this 
experiment was 40 U .24 h-’ . liver-‘. Although this 
was in good agreement with the 48 U calculated by 
the radioreceptor assay for other experiments, the 
concordance could be fortuitous. Rat GH (50 nglml) 
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Fig.2. The synthesis of bioactive somatomedln by cultured 
rat hepatocytes measured by the incorporation of “‘SO, into 
embryonic chicken pelvic cartilage. The viability of the 
cultured hepatocytes was > 95%. Each point is the mean 
2 SE of 5 observations. The calculated relative potencies 
2 95% fiducial Ilmits are listed at the bottom of each graph. 
(a) The log dose response curves of hepatocyte somatomedin 
compared to the standard serum. (b) The effect of 50 ng/ml 
of rat growth hormone on somatomedln synthesis. Growth 
hormone was added after 72 h and somatomedin production 
measured 24 h later. The lower incorporation of ‘ISO, in b 
was due to using 12 versus I 1 day old pelvic rudiments from 
a different supplier and a 4 h incubation period instead of 
6 h. 
stimulated SM release by 41% (fig.2b) compared with 
28% by radioreceptor assay. 
To learn whether cultured hepatoc~es ynthesized 
free or bound SM, culture media was ~romatographed 
on Sephadex G-75 at neutral pH to determine the 
approximate size of the SM complex. Under these 
conditions all of the SM synthesized by hepatocytes 
eluted just after human albumin and well ahead of 
free ‘?-labeled SM-A consistent with 4-5 X 104 
mol. wt (fig3a). Since free SM can be separated from 
its binding protein by chromatography on Sephadex 
under acidic conditions, hepatic SM was applied to a 
similar column equilibrated with 1 M acetic acid and 
found to coelute with free 12sI-labeled SM-A (fig3b) 
at -8000 mol. wt. On rec~omatography atneutral 
pH the free hepatic SM did not aggregate and then 
coeluted with free ‘2SI-labeled SM-A, demonstrating 
that the original arge molecular weight SM complex 
observed at neutral pH also contained the SM binding 
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F&3.3. ~omatog~phy of hepatic somatome~n on Sephadex 
G-75 (0.9 X 70 cm). (a) Chromatography at pH 7.4. (b) 
Chromatography in 1 M acetic acid. Recoveries were 85% 
and 78%, respectively. Column markers were human serum 
albumin (HSA), ‘251-labeled SM-A, and pyrldine (I’,). 
4. Discus8ion 
Rat hepatocytes in monolayer culture were found 
to synthesize SM continuously for at least 96 h and 
respond to maximal GH stimulation (150 ng/ml) with 
an increase of SM production of 36%. Measurements 
of SM synthesis by bioassay and radioreceptor assays 
were in good agreement indicating that the material 
released was bioactive. 
The use of hepatic parenchymal cells in monolayer 
culture offers many advantages for the study of the 
synthesis of SM and its binding protein. These cells 
have been shown [30] to maintain for several days 
metabolic functions characteristic of intact liver cells, 
synthesis of glycogen and albumin, gluconeogenesis 
from 3-carbon precursors, ensitivity to insulin and 
glucagon and active microsomal enzymes [30]. They 
are a u~fo~ pop~ation of cells that synthesize SM 
for at least 4 days, and respond to ng amounts of GH. 
They allow many variables to be controlled and thus 
far are the only method available for long term 
studies and investigating the intracellular mechanisms 
regulating SM synthesis. Perfused livers and suspension 
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cultures have limited usefulness because of decreased 
viability and deteriorating function was exemplified 
by the progressive fall in SM release near to zero after 
3 h perfusion [ 131. Since in perfused hypophy- 
sectomized rat livers GH only maintained control 
levels of SM release and merely slowed the decreasing 
release from normal livers, these effects of GH could 
be due to increased cell survival or decreased catab- 
olism of SM rather than actual stimulation of SM 
synthesis. This might explain the need for pharma- 
cologic doses of GH as opposed to ng amounts with 
cultured cells. 
SM in plasma is transported bound to a carrier 
protein and very little if any SM exists in a free 
state [21,22,38]. It is known that the binding pro- 
tein is a major determinant of the half-life of SM, 
for free SM is cleared by the body within minutes 
whereas the half-life of bound SM is 3-5 h in rats [2]. 
The production of this binding protein by hepatocytes 
establishes that the liver is its site of synthesis and 
that primary monolayer cultures can also be used to 
investigate its regulation. This protein has a special 
importance to endocrinology in that it is the only 
known binding protein for a polypeptide hormone. 
Whether the synthesis of the binding protein is 
independent [38] or correlated to [39] that of SM 
and how its synthesis is regulated are of major interest 
in understanding the biology of SM. 
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